Click for best price
Thyroid Cancer Molecular Diagnostics Market Size, Share 2023
A molecular approach for diagnosing thyroid cancer
This report aims to provide a comprehensive presentation of the global market for Thyroid Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Cancer Molecular Diagnostics. This report contains market size and forecasts of Thyroid Cancer Molecular Diagnostics in global, including the following market information:
Global Thyroid Cancer Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Thyroid Cancer Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Thyroid Cancer Molecular Diagnostics include Biomerieux, Mole, Genetronhealth, Berryoncology, Gene+, Annoroad, Topgen, Geneis and Kingmed, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Thyroid Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thyroid Cancer Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Thyroid Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Thyroid Cancer Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Thyroid Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Thyroid Cancer Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Thyroid Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thyroid Cancer Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Thyroid Cancer Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biomerieux
Mole
Genetronhealth
Berryoncology
Gene+
Annoroad
Topgen
Geneis
Kingmed
Unitedgene
Outline of Major Chapters:
Chapter 1: Introduces the definition of Thyroid Cancer Molecular Diagnostics, market overview.
Chapter 2: Global Thyroid Cancer Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Thyroid Cancer Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Thyroid Cancer Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Thyroid Cancer Molecular Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Thyroid Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Thyroid Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Thyroid Cancer Molecular Diagnostics Overall Market Size
2.1 Global Thyroid Cancer Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Thyroid Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Thyroid Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Thyroid Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Thyroid Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Thyroid Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Thyroid Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thyroid Cancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Thyroid Cancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Thyroid Cancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Thyroid Cancer Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Thyroid Cancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Thyroid Cancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Thyroid Cancer Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Thyroid Cancer Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Thyroid Cancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Thyroid Cancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Thyroid Cancer Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Thyroid Cancer Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Thyroid Cancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Thyroid Cancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Thyroid Cancer Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Thyroid Cancer Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Thyroid Cancer Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Thyroid Cancer Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Thyroid Cancer Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Thyroid Cancer Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Thyroid Cancer Molecular Diagnostics Market Size, 2018-2030
7 Thyroid Cancer Molecular Diagnostics Companies Profiles
7.1 Biomerieux
7.1.1 Biomerieux Company Summary
7.1.2 Biomerieux Business Overview
7.1.3 Biomerieux Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.1.4 Biomerieux Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Biomerieux Key News & Latest Developments
7.2 Mole
7.2.1 Mole Company Summary
7.2.2 Mole Business Overview
7.2.3 Mole Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.2.4 Mole Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Mole Key News & Latest Developments
7.3 Genetronhealth
7.3.1 Genetronhealth Company Summary
7.3.2 Genetronhealth Business Overview
7.3.3 Genetronhealth Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.3.4 Genetronhealth Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Genetronhealth Key News & Latest Developments
7.4 Berryoncology
7.4.1 Berryoncology Company Summary
7.4.2 Berryoncology Business Overview
7.4.3 Berryoncology Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.4.4 Berryoncology Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Berryoncology Key News & Latest Developments
7.5 Gene+
7.5.1 Gene+ Company Summary
7.5.2 Gene+ Business Overview
7.5.3 Gene+ Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.5.4 Gene+ Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Gene+ Key News & Latest Developments
7.6 Annoroad
7.6.1 Annoroad Company Summary
7.6.2 Annoroad Business Overview
7.6.3 Annoroad Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.6.4 Annoroad Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Annoroad Key News & Latest Developments
7.7 Topgen
7.7.1 Topgen Company Summary
7.7.2 Topgen Business Overview
7.7.3 Topgen Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.7.4 Topgen Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Topgen Key News & Latest Developments
7.8 Geneis
7.8.1 Geneis Company Summary
7.8.2 Geneis Business Overview
7.8.3 Geneis Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.8.4 Geneis Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Geneis Key News & Latest Developments
7.9 Kingmed
7.9.1 Kingmed Company Summary
7.9.2 Kingmed Business Overview
7.9.3 Kingmed Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.9.4 Kingmed Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Kingmed Key News & Latest Developments
7.10 Unitedgene
7.10.1 Unitedgene Company Summary
7.10.2 Unitedgene Business Overview
7.10.3 Unitedgene Thyroid Cancer Molecular Diagnostics Major Product Offerings
7.10.4 Unitedgene Thyroid Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Unitedgene Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Thyroid Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Thyroid Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Thyroid Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Thyroid Cancer Molecular Diagnostics in Global Market
Table 5. Top Thyroid Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Thyroid Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Thyroid Cancer Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Thyroid Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Thyroid Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thyroid Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Thyroid Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Thyroid Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Thyroid Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Thyroid Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Biomerieux Company Summary
Table 31. Biomerieux Thyroid Cancer Molecular Diagnostics Product Offerings
Table 32. Biomerieux Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Biomerieux Key News & Latest Developments
Table 34. Mole Company Summary
Table 35. Mole Thyroid Cancer Molecular Diagnostics Product Offerings
Table 36. Mole Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Mole Key News & Latest Developments
Table 38. Genetronhealth Company Summary
Table 39. Genetronhealth Thyroid Cancer Molecular Diagnostics Product Offerings
Table 40. Genetronhealth Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Genetronhealth Key News & Latest Developments
Table 42. Berryoncology Company Summary
Table 43. Berryoncology Thyroid Cancer Molecular Diagnostics Product Offerings
Table 44. Berryoncology Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Berryoncology Key News & Latest Developments
Table 46. Gene+ Company Summary
Table 47. Gene+ Thyroid Cancer Molecular Diagnostics Product Offerings
Table 48. Gene+ Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Gene+ Key News & Latest Developments
Table 50. Annoroad Company Summary
Table 51. Annoroad Thyroid Cancer Molecular Diagnostics Product Offerings
Table 52. Annoroad Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Annoroad Key News & Latest Developments
Table 54. Topgen Company Summary
Table 55. Topgen Thyroid Cancer Molecular Diagnostics Product Offerings
Table 56. Topgen Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Topgen Key News & Latest Developments
Table 58. Geneis Company Summary
Table 59. Geneis Thyroid Cancer Molecular Diagnostics Product Offerings
Table 60. Geneis Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Geneis Key News & Latest Developments
Table 62. Kingmed Company Summary
Table 63. Kingmed Thyroid Cancer Molecular Diagnostics Product Offerings
Table 64. Kingmed Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Kingmed Key News & Latest Developments
Table 66. Unitedgene Company Summary
Table 67. Unitedgene Thyroid Cancer Molecular Diagnostics Product Offerings
Table 68. Unitedgene Thyroid Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Unitedgene Key News & Latest Developments
List of Figures
Figure 1. Thyroid Cancer Molecular Diagnostics Segment by Type in 2022
Figure 2. Thyroid Cancer Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Thyroid Cancer Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Thyroid Cancer Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Thyroid Cancer Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thyroid Cancer Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Thyroid Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Thyroid Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Biomerieux Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Mole Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Genetronhealth Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Berryoncology Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Gene+ Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Annoroad Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Topgen Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Geneis Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Kingmed Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Unitedgene Thyroid Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
